Antibiotic therapy in the treatment of COVID-19 pneumonia: who and when?
Background: COVID-19 imposes challenges in antibiotic decision-making due to similarities between bacterial pneumonia and moderate to severe COVID-19. We evaluated the effects of antibiotic therapy on the clinical outcomes of COVID-19 pneumonia patients and diagnostic accuracy of key inflammatory ma...
Main Authors: | Ng, Tat Ming, Ong, Sean W. X., Loo, Audrey Y. X., Tan, Sock Hoon, Tay, Hui Lin, Yap, Min Yi, Lye, David C., Lee, Tau Hong, Young, Barnaby Edward |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Journal Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/165136 |
Similar Items
-
Sustaining antimicrobial stewardship in a high-antibiotic resistance setting
by: Ng, Tat Ming, et al.
Published: (2023) -
Real-world effectiveness of sotrovimab and remdesivir for early treatment of high-risk hospitalized COVID-19 patients: a propensity score adjusted retrospective cohort study
by: Koh, Lin Pin, et al.
Published: (2023) -
Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]
by: Poh, Xuan Ying, et al.
Published: (2023) -
The IDentif.AI-x pandemic readiness platform: rapid prioritization of optimized COVID-19 combination therapy regimens
by: Blasiak, Agata, et al.
Published: (2023) -
Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections
by: Goh, Yun Shan, et al.
Published: (2023)